These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7688982

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
    Hainsworth JD, Jones SE, Mennel RG, Blum JL, Greco FA.
    J Clin Oncol; 1996 May; 14(5):1611-6. PubMed ID: 8622079
    [Abstract] [Full Text] [Related]

  • 7. Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.
    Hainsworth JD, Andrews MB, Johnson DH, Greco FA.
    J Clin Oncol; 1991 Oct; 9(10):1731-5. PubMed ID: 1919624
    [Abstract] [Full Text] [Related]

  • 8. The importance of dose scheduling with mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer.
    Jolivet J, Bélanger K, Yelle L, Guévin R, Potvin M, Wilson J, Rudinskas L, Latreille J, Dionne J, Gagné L.
    Eur J Cancer; 1994 Oct; 30A(5):626-8. PubMed ID: 8080677
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mitoxantrone, 5-fluorouracil and high-dose leucovorin (NFL) in the treatment of metastatic breast cancer: randomized comparison to cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and attempts to improve efficacy by adding paclitaxel.
    Hainsworth JD.
    Eur J Cancer Care (Engl); 1997 Dec; 6(4 Suppl):4-9. PubMed ID: 9460336
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer.
    Jones SE, Mennel RG, Brooks B, Westrick MA, Allison MA, Paulson RS, Tilmann K, Rea B.
    J Clin Oncol; 1991 Oct; 9(10):1736-9. PubMed ID: 1919625
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer.
    Ingle JN, Kardinal CG, Suman VJ, Veeder MH, Schaefer PL, Kirschling RJ, Mailliard JA.
    Breast Cancer Res Treat; 1997 May; 43(3):193-200. PubMed ID: 9150898
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH.
    Anticancer Res; 2002 May; 22(6B):3621-7. PubMed ID: 12552966
    [Abstract] [Full Text] [Related]

  • 20. Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and well-tolerated regimen for the treatment of advanced breast cancer.
    Wils JA.
    Eur J Cancer; 1993 May; 29A(15):2106-8. PubMed ID: 8297648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.